Characterization of the Iatrogenic Drug Risk in Elderly Patients With Chronic Pain Who Consult the Pain Assessment and Treatment Centre at the Nimes University Hospital

NCT04006444 | Completed

• 1 other identifier: Local/2017/GL-01
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

Chronic pain may be an additional risk factor for drug iatrogeny due to its management and also drug non-compliance in the geriatric population. it seems interesting to carry out an inventory of the iatrogenic risk before and after the consultation at the pain centre to enable us to identify the patients most at risk. This study would make it possible to characterize elderly patients with chronic pain, in order to consider, in a future study, setting up a pharmaceutical consultation.

Conditions

Iatrogenic Drug Risk; Chronic Pain

Outcome Measures

Primary Outcomes (1)

• Evolution of the ADE Geriatric risk score

  The score is calculated on 10 points based on 3 criteria : number of drugs prescribed, prescription of neuroleptics and the initiation of an anticoagulant prescription less than 3 months old. It classifies patients into 3 risk categories: a low risk level for a score of 0 to 1 point, a medium risk level for a score of 2 to 5 points and a high risk level for a score of 6 to 10 points.

  2018

Secondary Outcomes (1)

• rate of patients with a low, medium or high risk level calculated by ADE Geriatric risk score according to the type of pain

  2018

Eligibility Criteria

• Age: 65 Years - 100 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

patients aged at least 65 years consulting at the pain centre of the Nîmes University Hospital for chronic pain

You may qualify if:

• The patient must be affiliated or beneficiary of a health insurance
• Patient ≥ 65 years old
• Having an outpatient consultation at the pain centre of the Nîmes University hospital of for chronic pain
• Available for pharmaceutical consultation about 30 minutes

You may not qualify if:

• It is impossible to give information
• The patient objects to participating in this study

Sponsors & Collaborators

• Centre Hospitalier Universitaire de Nīmes: lead

Study Sites (1)

CHU Nimes

Nîmes, 30029, France

Location

Related Publications (1)

• Jambon J, Choukroun C, Roux-Marson C, Viel E, Leguelinel-Blache G. What Is the Medication Iatrogenic Risk in Elderly Outpatients for Chronic Pain? Clin Neuropharmacol. 2022 May-Jun 01;45(3):65-71. doi: 10.1097/WNF.0000000000000505.

  PMID: 35579486 DERIVED

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• geraldine leguelinel, Dr

  CHU NIMES

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE CROSSOVER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 1, 2019
• First Posted: July 5, 2019
• Study Start: March 1, 2018
• Primary Completion: June 16, 2018
• Study Completion: June 16, 2018
• Last Updated: September 8, 2023

Record last verified: 2019-06

Locations

FR (1)